Almoosa Health: Q3 Loss Driven by Non-Cash Accounting Impact of Derivative Valuation, While Core Operations Remain Profitable and Expansion Plans Stay on Track

Almoosa Health Company reported a non-cash loss of SAR 81.9 million in the third quarter of 2026, resulting from the mark-to-market (MTM) valuation of ...

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.argaam.com)